2005 - Company creation
2008 - Partnership concluded with LFB (Laboratoire Français de Fractionnement et des Biotechnologies). Partnership concluded with Dometic Medical Systems. First trials of the Biolog® Transfusion solution conducted at Ile-de-France branch of the EFS (French Blood Service).
2009 – Study with EFS and healthcare establishments in the Loire region demonstrating relevance of Biolog®Transfusion solution and ROI in less than a year.
2010 – New company name: Biolog-id. The Grand Duchy of Luxemburg adopts the Biolog® solution for its transfusion system.
2011 – Partnership concluded with Fenwal USA / EMEA.
2012 - The State of Veracruz (Mexico) adopts Biolog®Transfusion technology. French Agency for Medicines and Health Products Safety (ANSM) authorizes Biolog®Fractionation to be marketed in France. Fenwal acquired by Fresenius Kabi, which therefore becomes Biolog-id’s new major partner.
2013 – Partnership concluded with Curie Institute regarding development of a traceability solution for chemotherapy injectables (C-Log®). FDA authorizes marketing in USA of RFID technology for traceability of blood products.
Biolog-id wins French tender for its Biolog® Transfusion solution. Solution assessed in the EFS Auvergne-Loire area. ISO 9001:2008 Certication. Eligibility approved for French Research Tax Credit.
2014 - Biolog ®Fractionation deployed in 11 sites across Europe (Austria, Hungary, Czech Republic, Bavaria). Registration of Biolog® solutions officially published in Russia.
First technical facility opens in Switzerland, at the La Chaux-de-Fonds and Neuchâtel La Providence Hospital Blood Transfusion Center (Génolier group). Biolog® Transfusion solution officially launched in Mexico, in the presence of the Mexican Minister of Health and numerous authorities on health issues
2015 – Deployment completed throughout the EFS of the Biolog®Fractionation solution developed for LFB. First tests of the C-Log® solution conducted at the Hôpital René Huguenin-Institut Curie.
2016 - Conception of the RFID portal for LFB to optimize reception of plasma of fractionation.
Biolog-id Receives “Best Solution for Industrial Smart Objects” Award.
2017- Commercial launch of C-log® for chemotherapy circuit in medical establisment.
Opening of our first two subsidiaries in Spain (Barcelona) and Italy (Milano)